Oosterwijk E - Search Results

1

Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study.

Schouten LJ, van Dijk BA, Oosterwijk E, Hulsbergen-van de Kaa CA, Kiemeney LA, Goldbohm RA, Schalken JA, van den Brandt PA. Schouten LJ, et al. Among authors: oosterwijk e. J Hypertens. 2005 Nov;23(11):1997-2004. doi: 10.1097/01.hjh.0000186023.74245.48. J Hypertens. 2005. PMID: 16208141

2

The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma.

Oosterwijk E, Debruyne FM, Schalken JA. Oosterwijk E, et al. Semin Oncol. 1995 Feb;22(1):34-41. Semin Oncol. 1995. PMID: 7855618 Review. No abstract available.

3

High energy shock waves induced increase in the local concentration of systemically given TNF-alpha.

Cornel EB, Oosterwijk E, van de Streek JD, Grutters G, Debruyne FM, Schalken JA, Oosterhof GO. Cornel EB, et al. Among authors: oosterwijk e. J Urol. 1994 Dec;152(6 Pt 1):2164-6. doi: 10.1016/s0022-5347(17)32344-3. J Urol. 1994. PMID: 7966708

4

Complex cadherin expression in renal cell carcinoma.

Shimazui T, Giroldi LA, Bringuier PP, Oosterwijk E, Schalken JA. Shimazui T, et al. Among authors: oosterwijk e. Cancer Res. 1996 Jul 15;56(14):3234-7. Cancer Res. 1996. PMID: 8764114

5

Molecular prognostic factor in renal cell carcinoma.

Shimazui T, Oosterwijk E, Debruyne FM, Schalken JA. Shimazui T, et al. Among authors: oosterwijk e. Semin Urol Oncol. 1996 Nov;14(4):250-5. Semin Urol Oncol. 1996. PMID: 8946626 Review.

6

Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinoma.

Shimazui T, Bringuier PP, van Berkel H, Ruijter E, Akaza H, Debruyne FM, Oosterwijk E, Schalken JA. Shimazui T, et al. Among authors: oosterwijk e. Int J Cancer. 1997 Oct 21;74(5):523-8. doi: 10.1002/(sici)1097-0215(19971021)74:5<523::aid-ijc8>3.0.co;2-5. Int J Cancer. 1997. PMID: 9355975

7

Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.

Shimazui T, Oosterwijk E, Akaza H, Bringuier P, Ruijter E, van Berkel H, Wakka JO, van Bokhoven A, Debruyne FM, Schalken JA. Shimazui T, et al. Among authors: oosterwijk e. Clin Cancer Res. 1998 Oct;4(10):2419-24. Clin Cancer Res. 1998. PMID: 9796973

8

Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinoma.

Shimazui T, Oosterwijk-Wakka J, Akaza H, Bringuier PP, Ruijter E, Debruyne FM, Schalken JA, Oosterwijk E. Shimazui T, et al. Among authors: oosterwijk e, oosterwijk wakka j. Eur Urol. 2000 Sep;38(3):331-8. doi: 10.1159/000020302. Eur Urol. 2000. PMID: 10940709

9

Renal cell carcinoma-associated G250 methylation and expression: in vivo and in vitro studies.

Grabmaier K, de Weijert M, Uemura H, Schalken J, Oosterwijk E. Grabmaier K, et al. Among authors: oosterwijk e. Urology. 2002 Aug;60(2):357-62. doi: 10.1016/s0090-4295(02)01711-9. Urology. 2002. PMID: 12137853

10

Role of complex cadherins in cell-cell adhesion evaluated by spheroid formation in renal cell carcinoma cell lines.

Shimazui T, Schalken JA, Kawai K, Kawamoto R, van Bockhoven A, Oosterwijk E, Akaza H. Shimazui T, et al. Among authors: oosterwijk e. Oncol Rep. 2004 Feb;11(2):357-60. Oncol Rep. 2004. PMID: 14719067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters